Abstract
The diagnostic accuracy of biomarker-based approaches can be considerably improved by combining multiple markers. A biomarker’s capacity to identify specific subjects is usually assessed using receiver operating characteristic (ROC) curves. Multimarker signatures are complicated to select as data signatures must be integrated using sophisticated statistical methods. CombiROC, developed as a user-friendly web tool, helps researchers to accurately determine optimal combinations of markers identified by a range of omics methods. With CombiROC, data of different types, such as proteomics and transcriptomics, can be analyzed using Sensitivity/Specificity filters: the number of candidate marker panels arising from combinatorial analysis is easily optimized bypassing limitations imposed by the nature of different experimental approaches. Users have full control over initial selection stringency, then CombiROC computes sensitivity and specificity for all marker combinations, determines performance for the best combinations, and produces ROC curves for automatic comparisons. All steps can be visualized in a graphic interface. CombiROC is designed without hard-coded thresholds, to allow customized fitting of each specific dataset: this approach dramatically reduces computational burden and false-negative rates compared to fixed thresholds. CombiROC can be accessed at www.combiroc.eu.
Key words
- Biomarker
- Protein
- miRNA
- ROC curve
- Statistical analysis
- Combinatorial analysis
- Multimarker signatures
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pfaffl MW (2013) Transcriptional biomarkers. Methods 59(1):1–2. https://doi.org/10.1016/j.ymeth.2012.12.011
Janvilisri T, Suzuki H, Scaria J et al (2015) High-throughput screening for biomarker discovery. Dis Markers 2015:108064. https://doi.org/10.1155/2015/108064
Sotiriou C, Piccart MJ (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7(7):545–553. https://doi.org/10.1038/nrc2173
Hainard A, Tiberti N, Robin X et al (2009) A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl Trop Dis 3(6):e459. https://doi.org/10.1371/journal.pntd.0000459
Turck N, Vutskits L, Sanchez-Pena P et al (2010) A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med 36(1):107–115. https://doi.org/10.1007/s00134-009-1641-y
Fung KYC, Tabor B, Buckley MJ et al (2015) Blood-based protein biomarker panel for the detection of colorectal cancer. PLoS One 10(3):e0120425. https://doi.org/10.1371/journal.pone.0120425
Li J, Zhang Z, Rosenzweig J et al (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48(8):1296–1304
Bombois S, Duhamel A, Salleron J et al (2013) A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer’s diagnosis. Curr Alzheimer Res 10(4):357–364. https://doi.org/10.2174/1567205011310040002
Zhang F, Deng Y, Drabier R (2013) Multiple biomarker panels for early detection of breast cancer in peripheral blood. Biomed Res Int 2013:781618. https://doi.org/10.1155/2013/781618
Buyse M, Michiels S, Sargent DJ et al (2011) Integrating biomarkers in clinical trials. Expert Rev Mol Diagn 11(2):171–182. https://doi.org/10.1586/erm.10.120
de Gramont A, Watson S, Ellis LM et al (2015) Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat Rev Clin Oncol 12(4):197–212. https://doi.org/10.1038/nrclinonc.2014.202
Kramar A, Faraggi D, Fortuné A et al (2001) mROC: a computer program for combining tumour markers in predicting disease states. Comput Methods Prog Biomed 66(2–3):199–207. https://doi.org/10.1016/S0169-2607(00)00129-2
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bombaci, M., Rossi, R.L. (2019). Computation and Selection of Optimal Biomarker Combinations by Integrative ROC Analysis Using CombiROC. In: Brun, V., Couté, Y. (eds) Proteomics for Biomarker Discovery. Methods in Molecular Biology, vol 1959. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9164-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9164-8_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9163-1
Online ISBN: 978-1-4939-9164-8
eBook Packages: Springer Protocols